NDC codes

FDA NDC Directory
Product NDC (as listed)74695-823Labeler and product segments. Claims need a package NDC.
Product NDC at billing width74695-0823Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
74695-823-18746950823181 CONTAINER in 1 CARTON (74695-823-18) / 1 BLISTER PACK in 1 CONTAINER / 18 CAPSULE in 1 BLISTER PACKMarketed from Jul 11, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Vivjoa
Generic name (nonproprietary)
oteseconazole
Active ingredients
Oteseconazole — 150 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Mycovia Pharmaceuticals, Inc.NDC labeler code 74695
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 215888
Marketing start
Listing expires
Other FDA classes
Azoles (Chemical structure)Breast Cancer Resistance Protein Inhibitors (Mechanism)
Identifiers
Product ID 74695-823_47e259e7-fa6d-849f-e063-6294a90aeba7SPL ID 47e259e7-fa6d-849f-e063-6294a90aeba7SPL set ID e21d5008-800e-4417-927f-14340341865fRxCUI 2602582, 2602588, 2605802, 2605803UNII VHH774W97N
Pharmacologic class
Azole Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N474695082318 followed by a unit qualifier and the quantity

Package 74695-0823-18. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

VIVJOA™ is an azole antifungal indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential. ( 1 ) 1.1 Vulvovaginal Candidiasis VIVJOA is indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential [see Warnings and Precautions (5.1) , Use in Specific Populations (8.3) , and Clinical Studies (14) ] . 1.2 Usage If specimens for fungal culture are obtained prior to therapy, antifungal therapy may be instituted before the results of the cultures are known. However, once these results become available, antifungal ther…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 74695-823

What is NDC 74695-823?
74695-823 is the product NDC for Vivjoa (oteseconazole), Oteseconazole 150 mg/1 capsule, listed with the FDA by Mycovia Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Vivjoa (Oteseconazole).
What is the active ingredient?
Oteseconazole.
Who is the labeler?
Mycovia Pharmaceuticals, Inc., NDC labeler code 74695. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vivjoa?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in